Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation

Journal of the American Academy of Dermatology

Volumn 46, Issue 1, 2002, Pages 133-137

  Calamia, Kenneth T ^a,b   Balabanova, Maria ^a,b   Perniciaro, Charles ^a,b   Walsh, John S ^a,b  

^a Medical University ^*  (United States)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; CELL PROLIFERATION; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENE MUTATION; HUMAN; LEG ULCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; THROMBOCYTE AGGREGATION; VASCULITIS; VEIN THROMBOSIS;

EID: 0036147699     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.117718     Document Type: Article

References (38)

1. Livedo vasculitis: Segmental hyalinizing vasculitis of the dermis
2. Risk factors for venous thrombosis: Prevalence, risk, and interaction
3. Resistance to activated protein C as a basis for venous thrombosis
4. Resistance to activated protein C: A common anticoagulant deficiency in patients with venous leg ulceration
5. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency
6. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
7. Livedo reticularis: A peripheral arteriolar disease
8. Livedo reticularis with ulcerations
9. Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis)
10. Les atrophies cutanées syphilitiques
11. Classification and therapy of atrophie blanche
12. Livedo vasculitis (the vasculitis of atrophie blanche): Immunohistopathologic study
13. Fibrinolytic therapy for vasculitis of atrophie blanche
14. Low-dose danazol in the treatment of livedoid vasculitis
15. Livedoid vasculitis with anticardiolipin antibodies: Improvement with danazol
16. Livedo reticularis with summer ulcerations: Report of a case treated with long-term anticoagulant therapy
17. Livedo reticularis with recurrent ulceration treated with anticoagulants
18. Livedo reticularis
19. Minidose heparin therapy for vasculitis of atrophie blanche
20. Antiplatelet therapy in atrophie blanche and livedo vasculitis
21. Atrophie blanche: Report of two patients treated with aspirin and dipyridamole
22. Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity
23. Antithrombotic treatment in livedo vasculitis
24. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche
25. Livedo vasculitis: Therapy with pentoxifylline
26. Therapy of livedo vasculitis with pentoxifylline
27. Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin
28. Livedo vasculitis: Vasculitis or thrombotic vasculopathy?
29. Atrophie blanche: A disorder associated with defective release of tissue plasminogen activator
30. Tissue plasminogen activator for treatment of livedoid vasculitis
31. Failure of livedoid vasculitis to respond to tissue plasminogen activator
32. Successful treatment of livedo vasculitis with beraprost sodium: A possible mechanism of thrombomodulin upregulation
33. Vasculopathy in the antiphospholipid syndrome: Thrombosis or vasculitis, or both?
34. Cutaneous manifestations associated with the presence of the lupus anticoagulant: A report of two cases and a review of the literature
35. Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant - The Sneddon syndrome: Report of 10 cases
36. Livedo vasculitis with protein C system deficiency
37. Homocysteinemia and livedoid vasculitis
38. Venous thrombosis - The interaction of genes and environment